Headquartered in New York, NY, VIVAX BIO is a global biotech company focusing on 3D bioprinting and working on the whole range of the hardware, materials, technologies, and products constituting this nascent industry. Our product pipeline – from the earliest stages of R&D to commercial manufacturing - comprises items as diverse as our FABION bioprinter, a new line of bioprinters based on different technologies, including in situ portable bioprinters, and various tissue and organ constructs.
Volumetric, Inc. was founded in 2018 by Jordan Miller and Bagrat Grigoryan. Our mission is to empower the next generation of advanced biofabrication with high quality materials and systems for 3D bioprinting.
3D Hydrogel and bioink company. | Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bioinks that are reproducible, scalable, easy to handle and suitable for clinical decision making.
BiogelxTM has launched a new range of bioinks which are optimized for use in 3D bioprinting and maintain all the benefits of our standard range of products. The BiogelxTM Inks are composed of synthetic peptide hydrogels which form a nanofibrous network, mimicking the extracellular-matrix which supports cell growth, signaling, and proliferation. Our new generation bio-inks have applications in fundamental cell research, toxicology, and drug screening, and may ultimately be translated to cell therapy or regenerative medicine
We are a Swedish biotechnology company with a global presence, offering cell culture matrices for culturing of primary cells. BioLamina is built on a scientific foundation with a legacy in matrix biology and solid experience in cell culture based research.
Founded in 2016, Qrons is a publicly traded, preclinical biotechnology company, developing advanced cell-based solutions to combat neurological injuries. While we are laser-focused on traumatic brain injury (TBI), our technology could potentially treat a wide range of neurodegenerative diseases.
Founded in 2014 by a team of leading experts with experience in biofabrication, SunP Biotech International (SunP) is a high-tech research and manufacturing company specialized in 3D bioprinting and tissue engineering.
CELLINK is an innovative biotechnology company and also the first bioink company in the world. Our vision is to create the future of medicine by creating the necessary tools for experts the world over to bioprint living human organs and tissue. We strive to make the bioprinting technology as accessible, user friendly and high performing as possible. We also collaborate with different organizations over the globe in pursuit of the same goal.
Established in 2004, New Harvest is the non-profit research institute building and establishing the field of cellular agriculture.
We strategically fund and conduct open, public, collaborative research that reinvents the way we make animal products - without animals.
Advanced BioMatrix is a leader in the life science of three dimensional (3D) applications for tissue culture, cell assay, and cell proliferation. Our products are recognized as the standard for purity, functionality, and consistency.
There are those who wish the world was different, and those who work to change it every day. At Modern Meadow we are working tirelessly to see this new future materialize; one where man (or woman) makes the material and the animals roam free.
Our team unites smart, passionate, and caring people who innovate new leather materials to excite customers and do better for the planet. Biology and materials science are our foundation, engineering and analytics our strength, and design our core. We're unlocking the capabilities of nature to solve our biggest sustainability challenges.
In 2004, InnoTERE was founded by Dr. Berthold Nies and took up its business in Dresden in 2005. As a result of our growth we moved to Pharmapark Radebeul at 1st January 2012. Since 2014 Erich Roethlisberger is our second Managing Director in the areas of marketing and sales.
Long-standing experiences in industrial research and development of biomaterials as well as the location in Dresden with its competences in materials science and biomaterials are solid basements for successful development of innovative products for bone tissue regeneration.
As an innovative company, we have set ourselves the target to explore, develop and produce in close collaboration with researchers and clinicians new products for the treatment of bone damage and finally market as medical devices. One of our development priorities form novel bone cements on the basis of calcium phosphates and polymers. These bone cements enable a minimally invasive treatment of bone defects.
We join together team members and cooperation partners who share our vision of innovative biomaterials for the well-being of affected patients. We further the creativity and skills of our team members and encourage their willingness to cooperate with interdisciplinary partners.
InnoTERE is a founding member of the innovation incentive "Molecular Designed Biological Coating" (MBC) promoted by the Federal Ministry of Education and Research (BMBF) lasting from 2007 to 2010, which was awarded "Selected Landmark 2008 in the Land of Ideas"
In 2008 InnoTERE was successfully certificated EN ISO 9001:2008 and EN ISO 13485:2012 in the scope of design/development, manufacturing and distribution of bone implants, bone cements and bone substitute materials.
RoosterBio is a products and technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time.
RoosterBio’s products are high volume, affordable, and well-characterized adult mesenchymal stem cells (MSCs) with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to time and costs savings for customers. Our innovative products are ushering in a new era of productivity and standardization into the field (as seen by customer product reviews), and researchers spend new found time & money performing more high-value experiments, accelerating the road to discovery in Regenerative Medicine.
RoosterBio's dedicated team has relevant technical, operational and regulatory experience and are considered leaders in the fields of Bio-manufacturing and Regenerative Medicine. The team has over 20 years of experience with the major cell and media supply companies including BD, Thermo Fisher (Life Technologies) and Lonza. The team are experts in cell and tissue technology, and have an intimate understanding of the cell supply needs of the industry.
RoosterBio leads the field of new-thinkers in stem cell research, cell and tissue engineering, and the commercialization of regenerative and biofabrication technologies. RoosterBio can be followed on our highly regarded blog Democratizing Cell Technologies.
Allevi, formerly known as BioBots is the 3D printer for biology. We are eliminating the organ waiting list to save tens of thousands of lives very year. We do this by building 3D bioprinter & accompanying printer cartridges that are accessible to both researchers at the frontier of regenerative medicine and non-specialists, such as high school biology teachers. By making this technology available and creating a community of users, we are lowering the barrier to entry into the field of regenerative medicine injecting a new dose of innovation into health care.
Roslin Cellab is a stem cell technology company, providing contract research, product development work and stem cell culture training for academic and commercial clients in the life science, biotechnology and pharmaceutical sectors. We provide you with the opportunity to explore and exploit stem cell biology and regenerative medicine. Our expert scientists come from Edinburgh University’s MRC Centre for Regenerative Medicine and the Roslin Institute and have many years experience of deriving, culturing and manipulating human stem cells in wide range of culture systems.